Ameritas Investment Partners’s Organon & Co OGN Stock Holding History

Ameritas Investment Partners’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,000	Closed	-$14.9K	–	3299
2025 Q1	$14.9K	Hold	1,000	–	–	﹤0.01%	2672
2024 Q4	$14.9K	Buy	+1,000	New	+$16.3K	﹤0.01%	2757
2023 Q4	–	Sell	-3,526	Closed	-$61.2K	–	3105
2023 Q3	$61.2K	Hold	3,526	–	–	﹤0.01%	1973
2023 Q2	$73.4K	Hold	3,526	–	–	﹤0.01%	1797
2023 Q1	$82.9K	Hold	3,526	–	–	﹤0.01%	1657
2022 Q4	$113K	Hold	3,526	–	–	﹤0.01%	1508
2022 Q3	$82K	Hold	3,526	–	–	﹤0.01%	1639
2022 Q2	$119K	Hold	3,526	–	–	0.01%	1391
2022 Q1	$123K	Hold	3,526	–	–	﹤0.01%	1498
2021 Q4	$107K	Sell	3,526 -1,165	-25%	-$37.9K	﹤0.01%	1636
2021 Q3	$154K	Sell	4,691 -241	-5%	-$7.71K	0.01%	1409
2021 Q2	$149K	Buy	+4,932	New	+$162K	0.01%	1463

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Ameritas Investment Partners's OGN Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 1,000 shares — an estimated $14.9K sold.

Ameritas Investment Partners first reported a position in OGN in Q2 2021 and held it in 12 quarters. The position peaked at $154K in Q3 2021. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

Ameritas Investment Partners reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
Ameritas Investment Partners sold 1,000 Organon & Co shares in Q2 2025, an estimated $14.9K.
Ameritas Investment Partners first reported a position in Organon & Co in Q2 2021 and held it in 12 quarters.
Ameritas Investment Partners's Organon & Co position peaked at $154K in Q3 2021.
695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.